Skip to content

Dietary Fiber Intake in Alcohol-dependent Patients

Dietary Fiber Intake in Alcohol-dependent Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03803709
Enrollment
40
Registered
2019-01-15
Start date
2017-07-04
Completion date
2022-07-31
Last updated
2019-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Keywords

dietary fibers, alcohol-dependent

Brief summary

The alcohol problem affects 7.5% of the population in Europe and represents a major public health problem. Alcoholism is also a major cause of undernutrition. Diet is a major factor influencing the composition of the intestinal microbiota and previous studies, carried out at Saint-Luc clinics and catholic university of Louvain, show that alcoholic patients suffer from dysbiosis, that is a significant alteration of the gut microbiota. The investigator's preliminary studies, carried out at the Integrated Unit of Hepatology of Saint-Luc Clinics, have shown that alcohol represents more than 40% of total caloric intake in alcohol-dependent patients. In addition, alcoholic patients have an insufficient intake of dietary fiber, that is to say a contribution lower than the Belgian nutritional recommendations. Indeed, the Conseil Supérieur de la Santé recommends a total amount of dietary fiber equal to or greater than 25 grams per day to ensure correct intestinal function. Fructan-type dietary fiber (inulin and fructo-oligosaccharides) is found naturally in many fruits and vegetables (Jerusalem artichokes, asparagus, artichokes, onions, garlic, chicory roots, bananas). They are neither absorbed nor digested by human enzymes but fermented selectively by intestinal bacteria. A good digestive tolerance to dietary fiber supplementation has been observed in healthy subjects as well as in obese patients, in previous studies conducted at catholic university of Louvain and Saint-Luc clinics. However, a nutritional rebalance via fiber supplementation and digestive fiber tolerance have never been tested in an alcohol-dependent population. The primary objectives of this academic research project in nutrition, carried out in alcohol-dependent patients, are as follows: 1. restore a nutritional balance as recommended by the Conseil Supérieur de la Santé via a dietary fiber intake 2. to study digestive tolerance to fibers 3. to study the intestinal and psychological well-being related to a fiber intake Depending on the results obtained during the achievement of the primary objectives, the biological samples (blood, stool) collected during the study will be used to analyze the composition of the intestinal microbiota and the plasma markers associated with intestinal function.

Interventions

DIETARY_SUPPLEMENTinulin

inulin given at different dosis from day 3 to day 20

DIETARY_SUPPLEMENTplacebo

maltodextrine given at different dosis from day 3 to day 20

Sponsors

Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* male or female * aged between 18 and 65 * caucasian * French speaking * alcohol drunk less than 48h before day 1

Exclusion criteria

* another addiction, except smoking * psychiatric comorbidity on axe 1 of Diagnostic and Statistical Manual-IV * antibiotic, probiotic or fibers recent (\<2 months) treatment (or other molecule modifying intestinal transit) * Non-steroidial anti-inflammatory drug or glucocorticoids recently taken (\<1 month) * obesity: Body Mass Index\<30 * bariatric surgery * Type 1 or 2 diabetes * chronic inflammatory diseases (Crohn disease, coeliac disease, rheumatoid arthritis) * cirrhosis or Advanced hepatic fibrosis (Fibroscan \> or = F3) * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in diet profileon Day 2 and Day 19This tool is based on the one adapted to alcoholic patients at Saint Luc Hospital. It consists of two parts to allow cross-checking of data (redundancy) and to measure separate information: General: it is implemented a Food Frequency Questionnaire (FFQ) in order to investigate the general diet profile. Daily: it resumes the sequencing of a full day which allows to verify the information previously obtained as well as to precisely identify the moments of consumption of alcoholic and non-alcoholic inputs. This 7-day recall will be carried out at two times: week T1 for reminder of the week before hospitalization then T2 for reminder of the week back home. In this last case, this anamnesis will be done by interview, but also on the basis of the diary filled by the patient in T2, in order to optimize the accuracy of the data.

Secondary

MeasureTime frameDescription
Quantitative evaluation of intakeson Day 2 and Day 19The meals will be weighted before and after eating
Alimentation historyOn day 21This questionnaire makes it possible to further investigate the patient's diet before the episode of alcoholism in his adult and child life. The aim is to assess whether it is closer to a healthy diet (Mediterranean diet or dash diet) or a Western diet type. It is based on the recall technique and performed by a qualified dietician.
Change in moodon Day 2 and Day 19Beck Depression Inventory (score 0-63). Higher score indicates higher depression level.
Change in anxietyon Day 2 and Day 19State-Trait Anxiety Inventory (score 20-80). Higher score indicates higher anxiety level.
Change in alcohol cravingon Day 2 and Day 19Obsessive Compulsive Drinking Scale: a total score (= obsession + compulsion) (0-40) and 2 sub-scores (Obsession (0-20) and Compulsion (0-20)) are calculated. Higher score indicates higher craving level.
Change in impulsivityon Day 2 and Day 19Urgency Premeditation Perseverance Sensation seeking impulsive behavior scale: score of different subscales are calculated: urgency(0-48), lack of premeditation(0-44), lack of perseverance(0-40), sensation seeking(0-48). Higher score in the different subscales indicates higher impulsivity level.
Change in selective attentionon Day 2 and Day 19William Lennox attention tests
Change in work memoryon Day 2 and Day 19Brown-Peterson's tasks
Alimentary bookFrom day 1 to day 21The patient will have to fill in this book every day
Change in inhibitionon Day 2 and Day 19Scoop's tasks
Change in decision makingon Day 2 and Day 19Iowa gambling's task
Change in traumaon Day 2 and Day 19Post-traumatic diagnostic scale: calculation of score is complex and described in the related publication Hearn, M, Ceschi, G., Brillon, P, Fürst, G., & Van der Linden, M. (2012). A French adaptation of the Post-traumatic Diagnostic scale. Canadian Journal of Behavioural Science, 44, 16-28.
Change in intestine integrityon Day 2 and Day 19It will be determined by blood sample (LPS level)
Change in albumin, pre-albumin and zinc concentrationon Day 2 and Day 19It will be determined by blood sample
Change in intestinal permeabilityon Day 2 and Day 19Patients will ingest 50microCurie of 51Chrome-Ethylenediamintetraacetic prepared in a Nutridrink®. This molecule is not normally absorbed by the intestine except when there is an increase in intestinal permeability (paracellular passage following rupture of tight junctions). The molecule is then filtered by the kidney and is found in the urine. A 24h urine collection will be carried out to measure the radioactivity emitted by 51Chrome-Ethylenediamintetraacetic
Change in fecal albumin concentrationon Day 2 and Day 19A stool sample will be collected to analyze a marker of intestinal permeability: fecal albumin
Intestinal permeabilityOn day 3a duodenal biopsy will be collected and the expression of the tight junctions regulating the intestinal permeability will be analyzed by sectional immunofluorescence and quantitative Polymerase Chain reaction
Change in flexibilityon Day 2 and Day 19Trail making test

Countries

Belgium

Contacts

Primary ContactPeter Stärkel, MD, PhD
peter.starkel@uclouvain.be003227642853

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026